サマリー

世界のタンパク質工学市場 2023-2027
プロテインエンジニアリング市場は、2022-2027年に2億3,789万米ドルの成長が予測され、予測期間中のCAGRは15.42%で加速すると予測されています。この調査レポートは、タンパク質工学市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、改善された食品や工業製品への需要、慢性疾患の有病率の上昇、新しい生物製造プロセスの開発によって牽引されています。
Technavioのタンパク質工学市場は以下のように区分される：
製品別
- 機器
- 試薬
エンドユーザー別
- 製薬・バイオテクノロジー企業
- 受託研究機関
- 学術研究機関
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、タンパク質工学におけるジェネレーティブAIの採用が、今後数年間のタンパク質工学市場の成長を促進する主要な理由の1つであると特定している。また、タンパク質ベースの医薬品や治療法に対する需要の増加、個別化医療への注目の高まりは、同市場の大きな需要につながる。
本レポートでは、タンパク質工学市場について以下の分野をカバーしています：
- タンパク質工学市場のサイジング
- タンパク質工学市場の予測
- タンパク質工学市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Agilent Technologies Inc、Bio Rad Laboratories Inc.、Bruker Corp.、Danaher Corp.、Eli Lilly and Co.、General Electric Co.、GenScript Biotech Corp.、Merck KGaA、New England Biolabs Inc.、Novo Nordisk AS、PerkinElmer Inc.、Promega Corp.、Thermo Fisher Scientific Inc.、Waters Corp.などである。また、タンパク質工学市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものである。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/protein-engineering-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global protein engineering market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global protein engineering market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 End-User Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Instruments - Market size and forecast 2022-2027
o Exhibit 34: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Instruments - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
o 6.4 Reagents - Market size and forecast 2022-2027
o Exhibit 38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
o Exhibit 48: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
o 7.4 Contract research organizations - Market size and forecast 2022-2027
o Exhibit 52: Chart on Contract research organizations - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Contract research organizations - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Contract research organizations - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Contract research organizations - Year-over-year growth 2022-2027 (%)
o 7.5 Academic research institutes - Market size and forecast 2022-2027
o Exhibit 56: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ million)
o Exhibit 61: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 111: Agilent Technologies Inc. - Overview
o Exhibit 112: Agilent Technologies Inc. - Business segments
o Exhibit 113: Agilent Technologies Inc. - Key offerings
o Exhibit 114: Agilent Technologies Inc. - Segment focus
o 12.4 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 12.5 Bio Rad Laboratories Inc.
o Exhibit 118: Bio Rad Laboratories Inc. - Overview
o Exhibit 119: Bio Rad Laboratories Inc. - Business segments
o Exhibit 120: Bio Rad Laboratories Inc. - Key news
o Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
o 12.6 Bruker Corp.
o Exhibit 123: Bruker Corp. - Overview
o Exhibit 124: Bruker Corp. - Business segments
o Exhibit 125: Bruker Corp. - Key news
o Exhibit 126: Bruker Corp. - Key offerings
o Exhibit 127: Bruker Corp. - Segment focus
o 12.7 Danaher Corp.
o Exhibit 128: Danaher Corp. - Overview
o Exhibit 129: Danaher Corp. - Business segments
o Exhibit 130: Danaher Corp. - Key news
o Exhibit 131: Danaher Corp. - Key offerings
o Exhibit 132: Danaher Corp. - Segment focus
o 12.8 Eli Lilly and Co.
o Exhibit 133: Eli Lilly and Co. - Overview
o Exhibit 134: Eli Lilly and Co. - Product / Service
o Exhibit 135: Eli Lilly and Co. - Key news
o Exhibit 136: Eli Lilly and Co. - Key offerings
o 12.9 General Electric Co.
o Exhibit 137: General Electric Co. - Overview
o Exhibit 138: General Electric Co. - Business segments
o Exhibit 139: General Electric Co. - Key news
o Exhibit 140: General Electric Co. - Key offerings
o Exhibit 141: General Electric Co. - Segment focus
o 12.10 GenScript Biotech Corp.
o Exhibit 142: GenScript Biotech Corp. - Overview
o Exhibit 143: GenScript Biotech Corp. - Business segments
o Exhibit 144: GenScript Biotech Corp. - Key news
o Exhibit 145: GenScript Biotech Corp. - Key offerings
o Exhibit 146: GenScript Biotech Corp. - Segment focus
o 12.11 Merck KGaA
o Exhibit 147: Merck KGaA - Overview
o Exhibit 148: Merck KGaA - Business segments
o Exhibit 149: Merck KGaA - Key news
o Exhibit 150: Merck KGaA - Key offerings
o Exhibit 151: Merck KGaA - Segment focus
o 12.12 New England Biolabs Inc.
o Exhibit 152: New England Biolabs Inc. - Overview
o Exhibit 153: New England Biolabs Inc. - Product / Service
o Exhibit 154: New England Biolabs Inc. - Key offerings
o 12.13 Novo Nordisk AS
o Exhibit 155: Novo Nordisk AS - Overview
o Exhibit 156: Novo Nordisk AS - Business segments
o Exhibit 157: Novo Nordisk AS - Key offerings
o Exhibit 158: Novo Nordisk AS - Segment focus
o 12.14 PerkinElmer Inc.
o Exhibit 159: PerkinElmer Inc. - Overview
o Exhibit 160: PerkinElmer Inc. - Business segments
o Exhibit 161: PerkinElmer Inc. - Key news
o Exhibit 162: PerkinElmer Inc. - Key offerings
o Exhibit 163: PerkinElmer Inc. - Segment focus
o 12.15 Promega Corp.
o Exhibit 164: Promega Corp. - Overview
o Exhibit 165: Promega Corp. - Product / Service
o Exhibit 166: Promega Corp. - Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 167: Thermo Fisher Scientific Inc. - Overview
o Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 169: Thermo Fisher Scientific Inc. - Key news
o Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
o 12.17 Waters Corp.
o Exhibit 172: Waters Corp. - Overview
o Exhibit 173: Waters Corp. - Business segments
o Exhibit 174: Waters Corp. - Key news
o Exhibit 175: Waters Corp. - Key offerings
o Exhibit 176: Waters Corp. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global protein engineering market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-User Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on End-user - Market share 2022-2027 (%)
Exhibits45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Contract research organizations - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Contract research organizations - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Contract research organizations - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Contract research organizations - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Academic research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Academic research institutes - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Academic research institutes - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Academic research institutes - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Agilent Technologies Inc. - Overview
Exhibits112: Agilent Technologies Inc. - Business segments
Exhibits113: Agilent Technologies Inc. - Key offerings
Exhibits114: Agilent Technologies Inc. - Segment focus
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: Bio Rad Laboratories Inc. - Overview
Exhibits119: Bio Rad Laboratories Inc. - Business segments
Exhibits120: Bio Rad Laboratories Inc. - Key news
Exhibits121: Bio Rad Laboratories Inc. - Key offerings
Exhibits122: Bio Rad Laboratories Inc. - Segment focus
Exhibits123: Bruker Corp. - Overview
Exhibits124: Bruker Corp. - Business segments
Exhibits125: Bruker Corp. - Key news
Exhibits126: Bruker Corp. - Key offerings
Exhibits127: Bruker Corp. - Segment focus
Exhibits128: Danaher Corp. - Overview
Exhibits129: Danaher Corp. - Business segments
Exhibits130: Danaher Corp. - Key news
Exhibits131: Danaher Corp. - Key offerings
Exhibits132: Danaher Corp. - Segment focus
Exhibits133: Eli Lilly and Co. - Overview
Exhibits134: Eli Lilly and Co. - Product / Service
Exhibits135: Eli Lilly and Co. - Key news
Exhibits136: Eli Lilly and Co. - Key offerings
Exhibits137: General Electric Co. - Overview
Exhibits138: General Electric Co. - Business segments
Exhibits139: General Electric Co. - Key news
Exhibits140: General Electric Co. - Key offerings
Exhibits141: General Electric Co. - Segment focus
Exhibits142: GenScript Biotech Corp. - Overview
Exhibits143: GenScript Biotech Corp. - Business segments
Exhibits144: GenScript Biotech Corp. - Key news
Exhibits145: GenScript Biotech Corp. - Key offerings
Exhibits146: GenScript Biotech Corp. - Segment focus
Exhibits147: Merck KGaA - Overview
Exhibits148: Merck KGaA - Business segments
Exhibits149: Merck KGaA - Key news
Exhibits150: Merck KGaA - Key offerings
Exhibits151: Merck KGaA - Segment focus
Exhibits152: New England Biolabs Inc. - Overview
Exhibits153: New England Biolabs Inc. - Product / Service
Exhibits154: New England Biolabs Inc. - Key offerings
Exhibits155: Novo Nordisk AS - Overview
Exhibits156: Novo Nordisk AS - Business segments
Exhibits157: Novo Nordisk AS - Key offerings
Exhibits158: Novo Nordisk AS - Segment focus
Exhibits159: PerkinElmer Inc. - Overview
Exhibits160: PerkinElmer Inc. - Business segments
Exhibits161: PerkinElmer Inc. - Key news
Exhibits162: PerkinElmer Inc. - Key offerings
Exhibits163: PerkinElmer Inc. - Segment focus
Exhibits164: Promega Corp. - Overview
Exhibits165: Promega Corp. - Product / Service
Exhibits166: Promega Corp. - Key offerings
Exhibits167: Thermo Fisher Scientific Inc. - Overview
Exhibits168: Thermo Fisher Scientific Inc. - Business segments
Exhibits169: Thermo Fisher Scientific Inc. - Key news
Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits172: Waters Corp. - Overview
Exhibits173: Waters Corp. - Business segments
Exhibits174: Waters Corp. - Key news
Exhibits175: Waters Corp. - Key offerings
Exhibits176: Waters Corp. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations